Vemurafenib-induced pancreatitis in a patient with recurrent hairy cell leukaemia.
Publication Date
2020
Journal Title
BMJ Case Rep
Abstract
Recent studies have shown that BRAF inhibitors, such as vemurafenib, are effective in inducing long periods of remission in relapsed hairy cell leukaemia. Acute pancreatitis is one of the rare complications that is reported with vemurafenib use. As severe pancreatitis can be life threatening, physicians should be vigilant of this side effect and promptly treat patients that develop clinical signs and symptoms while receiving vemurafenib. We present an interesting case of vemurafenib-induced pancreatitis that not only resolved but also did not recur after reintroduction of the drug at a reduced dose.
Volume Number
13
Issue Number
9
Pages
e236073
Document Type
Article
Status
Faculty, Northwell Resident
Facility
School of Medicine; Northwell Health
Primary Department
General Internal Medicine
PMID
DOI
10.1136/bcr-2020-236073